Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
5,967,794
-
Shares change
-
-167,890
-
Total reported value, excl. options
-
$46,727,000
-
Value change
-
-$1,774,037
-
Number of buys
-
13
-
Number of sells
-
-16
-
Price
-
$7.83
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2019
41 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2019.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,967,794 shares
of 13,838,977 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2,011,882 shares), NEA Management Company, LLC (1,562,500 shares), VANGUARD GROUP INC (265,122 shares), CADENCE CAPITAL MANAGEMENT LLC (264,491 shares), RENAISSANCE TECHNOLOGIES LLC (180,646 shares), DIMENSIONAL FUND ADVISORS LP (155,498 shares), WELLS FARGO & COMPANY/MN (149,100 shares), INGALLS & SNYDER LLC (146,046 shares), PERKINS CAPITAL MANAGEMENT INC (142,550 shares), and ESSEX INVESTMENT MANAGEMENT CO LLC (138,232 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.